相关实验视频

Updated: Jun 5, 2025

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

在糖尿病酸性症中优化风险分层:利用观测数据重新评估酸状态和超度

Sebastiaan Paul Blank¹, Ruth Miriam Blank²

¹Intensive Care Unit, Royal Darwin Hospital, Darwin, NT, 0810, Australia. sebastiaan.blank@mail.com.

Internal and emergency medicine

|December 6, 2024

概括

糖尿病酸性脂肪酸症 (DKA) 严重程度的评估至关重要. 高度和低pH预测死亡率,而二碳酸盐和离子间隙不能有效预测DKA患者的结果.

科学领域:

内分泌学在内分泌学.
关键护理医学关键护理医学
腎臟病學 (nephrology) 是一種醫學專業.

背景情况:

准确的糖尿病酸症 (DKA) 严重程度评估对于及时管理和资源分配至关重要.
对于DKA严重程度的现有生物标志物缺乏与患者结果的一致相关性.
超度和酸性是DKA的关键特征,需要精确的评估.

研究的目的:

调查DKA严重性标志物 (酸性,高度) 与医院死亡率之间的关联.
在DKA患者中确定重症监护室 (ICU) 死亡率,机械呼吸,血管压缩剂使用和透析的预测因素.
评估血清二碳酸盐,离子间隙和pH在预测DKA结果中的有用性.

主要方法:

用MIMIC-IV和eICU数据库对美国ICU中成人DKA入院的回顾性队列研究.
在入院后4小时内对生物化学参数 (pH,二碳酸盐,离子间隙,度) 进行分析.
后勤回归模型用于评估严重性标志物与初级/二级结果之间的关系.

主要成果:

血清二碳酸盐或离子间隙与死亡率或其他结果之间没有明确的关联.
pH < 7 和不适当高的 PCO2 与增加的死亡率和二次结果有关.
度≥320mOsm/L与死亡率增加四倍和机械通风,血管压缩剂和透析的更高率相关.

结论:

通过适应机制的失败表明的生理不补偿,对于DKA风险分层可能比单独的酸性病的程度更为关键.
血液气体分析,特别是pH值,对于充分评估DKA的严重程度至关重要.
血清二碳酸盐和离子间隙不是对DKA结果的可靠预测指标.

关键词:

这是一种酸性化症.糖尿病酸性酸性过高血糖症的发生.奥斯摩拉性是指奥斯摩拉性.

更多相关视频

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis

Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis

Published on: October 2, 2020

相关概念视频

Diabetes: Symptoms, Diagnosis, and Complications

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...

Hypoglycemia and Glucagon

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...